Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Documentation

  • Home >
  • Investors & media >
  • Documentation
07 May 2024
General Assembly, General meetings

Rapport AK réservée aux salariés Open in new window

07 May 2024
General Assembly, General meetings

Rapport sur OCA Open in new window

07 May 2024
General Assembly, General meetings

Rapport attribution AGA Open in new window

07 May 2024
General Assembly, General meetings

Rapport sur attribution de SO Open in new window

07 May 2024
General Assembly, General meetings

Rapport sur attribution de BSA Open in new window

07 May 2024
General Assembly, General meetings

Rapport délégation globale Open in new window

07 May 2024
General Assembly, General meetings

Rapport sur la réduction du capital Open in new window

07 May 2024
General Assembly, General meetings

Rapport complémentaire primary bid Open in new window

07 May 2024
General Assembly, General meetings

Rapport complémentaire catégorie de personne Open in new window

07 May 2024
General Assembly, General meetings

Rapport spécial des commissaires aux comptes sur les conventions réglementées 2023 Open in new window

  • View previous 9 articles
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 23
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page